
Hypertension

Management of Hypertension in Diabetic Nephropathy Patients - Dr. SP Chan
Join Dr. S. P. Chan, Consultant Endocrinologist, as she discusses key principles in managing hypertension in patients with diabetes, with a special focus on diabetic nephropathy.
In this video, Dr. Chan answers frequently asked questions and shares practical insights to help healthcare professionals optimize care and protect kidney health in diabetic patients.

Self-reported single adherence question scored on a visual analogue scale predicts cardiovascular outcomes and mortality
Single self-reported adherence question can help identify patients with low medication adherence and its impact on BP control, LDL-C levels, CV events, and all-cause mortality. This single-question approach can be easily incorporated into routine medical history taking.

Angiotensin-converting enzyme inhibitors versus angiotensin receptor blockers in patients with hypertension
This retrospective study showed that use of ARBs was associated with similar cardiovascular outcomes as compared to the use of ACEi in the management of patients with primary hypertension.

Effect of ARB-based therapy in hypertensive patients with hyperuricemia and microalbuminuria
This study highlighted that ARB monotherapy, and its combination with diuretic or/ CCB, significantly decreased SBP, however, ARB monotherapy and its combination with CCB can improve uric acid and urinary albumin/creatinine ratio (UACR) level in hypertensive patients with hyperuricemia, and microalbuminuria.

Personalized Hypertension Management: Watch Prof. Konstantinos Tsioufis's expert video
ESC/ESH recommend SPC therapy: ACEI/ARB + diuretic/CCB. Though ACEIs and ARBs are equally effective, ARBs are preferred in most patients.1,2
ARBs have been proven to have cardioprotective and renoprotective effects, especially irbesartan.3
RAS blockers (esp. ARBs) + CCBs are preferred agents for hypertension management due to their multiple beneficial effects on the circulatory system4

Effect of intensive blood pressure (BP) control treatment on long-term all-cause and cardiovascular (CV) mortality in patients with hypertension

Comparison of American College of Cardiology/American Heart Association and European Society of Cardiology/European Society of Hypertension blood pressure/ hypertension guidelines
Please log in or register to continue reading.
Login For Healthcare Professionals
HCP Verification Required
We are in the midst of verifying your registration. You will receive an email confirmation to access Campus Sanofi once your verification is complete.
RESEND SUCCESS
Please check you email for verification emali.
Restricted Content
You do not have the correct verified role to view this content.
You are almost set!
Success
Thank you for registering. Please validate your email by clicking on the link in the email sent to you. Once your registration has been validated, you will receive a confirmation email to log in to Campus Sanofi.
Patient-Video

Request-form
